Dario Altieri
-
Researchers from Wistar Institute, ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could…
-
Wistar Institute Welcomes James Lovett to Board of Trustees
The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome James Lovett to its Board of…
-
Wistar Institute Receives Exceptional Rating in Renewal of its Cancer Center Support Grant
The National Cancer Institute (NCI) rated The Wistar Institute’s Ellen and Ronald Caplan Cancer Center as “exceptional” for the third time in a row during the renewal of…
-
Wistar Institute Appoints Katherine Aird, Ph.D., to Ellen and Ronald Caplan Cancer Center
The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, has announced the appointment of Katherine Aird, Ph.D., as co-leader and professor…
-
Wistar Institute Recruits Computational Biologist Simon Chu, Ph.D., as Caspar Wistar Fellow in the Caplan Cancer Center
The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious disease, has announced the appointment of Simon Chu, Ph.D., as Caspar Wistar Fellow in the Molecular…
-
Wistar Institute Opens New Center for Advanced Therapeutics, CEO Talks Goals and Vision
The Wistar Institute recently launched its newest initiative, the Center for Advanced Therapeutics, further aligning with Philadelphia’s growing life sciences sector and further expanding Wistar’s…


































